Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-11

Clinical Trial Update: Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a probiotic in adult patients with drug-resistant epilepsy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic (probiotic)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Epilepsy, Treatment | Phase 4 | Status: COMPLETED